Bio-Techne shareholders approve Merck KGaA acquisition
Shareholders voted at a September 23 special meeting to back the merger, clearing a major step toward closing.
SEC filing
Latest
2 stories
Wednesday, September 23
Wednesday, August 12
Bio-Techne posts Q4 FY2026 results as Merck KGaA acquisition proceeds
Bio-Techne reported fourth quarter and full-year fiscal 2026 results while confirming progress toward its previously disclosed acquisition by Merck KGaA, Darmstadt, Germany.
SEC filing